OnsetRx is an independent medical‑information resource focused on clinically‑neutral, evidence‑based coverage of PDE5 inhibitors, including vardenafil, sildenafil, and tadalafil. Our goal is to provide clear, structured, medically‑reviewed content that helps users understand mechanisms, onset characteristics, dosage ranges, safety considerations, and formulation differences — without marketing influence or promotional bias.
The mission of OnsetRx is to deliver reliable, medically‑neutral information about PDE5 inhibitors with transparent sourcing, clear editorial standards, and strict separation between medical review and content production. We focus on accuracy, clarity, and safety, ensuring that every page reflects current clinical understanding and pharmacological evidence.
All medical content undergoes structured review by qualified medical professionals. Our review process is documented in the Medical Review Policy, which outlines how clinical accuracy, pharmacological consistency, and safety relevance are validated before publication.
Editorial independence is equally important. Our internal guidelines ensure that content remains unbiased, medically‑neutral, and free from commercial influence. Full details are available in the Editorial Policy.
OnsetRx maintains a clear separation between medical review, editorial processes, and operational management. We publish dedicated trust‑cluster pages to ensure transparency across all aspects of content creation:
Users may reach our editorial or medical review teams through the Contact Page. We respond to inquiries related to content accuracy, medical review clarification, and editorial transparency.